These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes. Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321 [TBL] [Abstract][Full Text] [Related]
9. Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization. Gotoh T; Nakahara K; Nishiura T; Hashimoto M; Kino T; Kuroda Y; Okuhara M; Kohsaka M; Aoki H; Imanaka H J Antibiot (Tokyo); 1982 Oct; 35(10):1286-92. PubMed ID: 6757224 [TBL] [Abstract][Full Text] [Related]
10. A new immunomodulator, FR-900490. Shibata T; Nakayama O; Okuhara M; Tsurumi Y; Terano H; Kohsaka M J Antibiot (Tokyo); 1988 Sep; 41(9):1163-9. PubMed ID: 3141334 [TBL] [Abstract][Full Text] [Related]
11. Effect of an immunopotentiator on Aeromonas salmonicida infection in rainbow trout (Salmo gairdneri). Kitao T; Yoshida Y Vet Immunol Immunopathol; 1986 Jun; 12(1-4):287-96. PubMed ID: 3765348 [TBL] [Abstract][Full Text] [Related]
12. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro. Ahmed K; Turk JL Cancer Immunol Immunother; 1989; 28(2):87-92. PubMed ID: 2783891 [TBL] [Abstract][Full Text] [Related]
13. Studies on a new immunoactive peptide, FK-156. I. Taxonomy of the producing strains. Gotoh T; Nakahara K; Iwami M; Aoki H; Imanaka H J Antibiot (Tokyo); 1982 Oct; 35(10):1280-5. PubMed ID: 7174515 [No Abstract] [Full Text] [Related]
14. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity. Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711 [No Abstract] [Full Text] [Related]
15. Studies on a new immunoactive peptide, FK-156. III. Structure elucidation. Kawai Y; Nakahara K; Gotoh T; Uchida I; Tanaka H; Imanaka H J Antibiot (Tokyo); 1982 Oct; 35(10):1293-9. PubMed ID: 7174516 [No Abstract] [Full Text] [Related]
16. Studies on a new immunoactive peptide, FK-156. IV. Synthesis of FK-156 and its geometric isomer. Hemmi K; Aratani M; Takeno H; Okada S; Miyazaki Y; Nakaguchi O; Kitaura Y; Hashimoto M J Antibiot (Tokyo); 1982 Oct; 35(10):1300-11. PubMed ID: 7174517 [TBL] [Abstract][Full Text] [Related]
17. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156. Takeno H; Okada S; Yonishi S; Hemmi K; Nakaguchi O; Kitaura Y; Hashimoto M Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2932-41. PubMed ID: 6518579 [No Abstract] [Full Text] [Related]
18. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156. Takeno H; Okada S; Hemmi K; Aratani M; Kitaura Y; Hashimoto M Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2925-31. PubMed ID: 6518578 [No Abstract] [Full Text] [Related]
19. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine. Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131 [No Abstract] [Full Text] [Related]
20. Macrophage involvement in the antitumor activity of a synthetic acyltripeptide (FK-565) against experimental lung carcinoma metastases. Schultz RM; Altom MG J Immunopharmacol; 1986; 8(4):515-28. PubMed ID: 3543138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]